Aims and Scope

OncoDaily Medical Journal, OncoDaily Medical Journal (ODMJ) is a peer-reviewed, open-access publication committed to advancing the field of oncology by comprehensively covering all facets of cancer research and treatment. We provide an international platform for the oncology community to disseminate significant scientific advancements, clinical developments, and expert insights that contribute to improved cancer outcomes worldwide. Emphasizing a multidisciplinary approach, OncoDaily Medical Journal encourages submissions across a broad spectrum of oncological research—from molecular and translational science to clinical trials, public health, supportive care, and patient-centered strategies. We are committed to facilitating the global exchange of innovative ideas and findings among researchers, clinicians, and healthcare professionals, thereby enhancing the understanding, management, and care of patients with cancer.
The journal welcomes a wide range of study types, including original research, reviews, case reports, commentaries, and expert perspectives.

Editorial Leadership

Published under the editorial leadership of Chair of the Editorial Board Dr. Matti Aapro and Editor-in-Chief Dr. Shushan Hovsepyan, ODMJ is supported by a diverse international editorial board and is the official journal of the Immune Oncology Research Institute.

Open Access Policy

OncoDaily Medical Journal is dedicated to disseminating medical knowledge freely and universally through our open access policy. This approach ensures that researchers worldwide can access, use, and build upon the work published in our journal.

Journal Sections

Our journal is structured into specialized sections, each led by expert editors who ensure that the content meets the highest standards of rigor and relevance. When submitting, authors are encouraged to choose the section that best aligns with their research to facilitate a fair and expert review process.